Many biotech companies reach a stage where they need senior commercial leadership but cannot justify hiring a full-time executive.
This is why fractional consultants and fractional executives are becoming increasingly popular.
Fractional leaders provide:
-
Strategic expertise
-
Hands-on execution
-
Flexibility and lower cost than full-time hires
Companies gain access to experienced leadership without the financial commitment of a permanent executive role.
For startups and growth-stage companies, this model accelerates commercialization while minimizing risk.